Publications found:
58,333
Sort by:
Leiomyosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF LEIOMYOSARCOMA PIPELINE REPORT INCLUDES Panorama of Leiomyosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
200 pages
Leishmaniasis (Kala Azar) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LEISHMANIASIS (KALA AZAR) PIPELINE REPORT INCLUDES Panorama of Leishmaniasis (Kala Azar) pipeline markets including statistics on therapeutic drugs and companies involved Leishmaniasis (Kala Azar) Pipeline candidates across various development ...
August 2018
100 pages
Lennox Gastaut Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LENNOX GASTAUT SYNDROME PIPELINE REPORT INCLUDES Panorama of Lennox Gastaut Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Lennox Gastaut Syndrome Pipeline candidates across various development ...
August 2018
50 pages
Lewy body Dementia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LEWY BODY DEMENTIA PIPELINE REPORT INCLUDES Panorama of Lewy body Dementia pipeline markets including statistics on therapeutic drugs and companies involved Lewy body Dementia Pipeline candidates across various development ...
August 2018
40 pages
Lipodystrophy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF LIPODYSTROPHY PIPELINE REPORT INCLUDES Panorama of Lipodystrophy pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Liposarcoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF LIPOSARCOMA PIPELINE REPORT INCLUDES Panorama of Liposarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
130 pages
Liver Cirrhosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LIVER CIRRHOSIS PIPELINE REPORT INCLUDES Panorama of Liver Cirrhosis pipeline markets including statistics on therapeutic drugs and companies involved Liver Cirrhosis Pipeline candidates across various development ...
August 2018
70 pages
Liver Transplant Rejection R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LIVER TRANSPLANT REJECTION PIPELINE REPORT INCLUDES Panorama of Liver Transplant Rejection pipeline markets including statistics on therapeutic drugs and companies involved Liver Transplant Rejection Pipeline candidates across various development ...
August 2018
60 pages
Low Back Pain R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LOW BACK PAIN PIPELINE REPORT INCLUDES Panorama of Low Back Pain pipeline markets including statistics on therapeutic drugs and companies involved Low Back Pain Pipeline candidates across various development ...
August 2018
80 pages
Lung Transplant Rejection R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LUNG TRANSPLANT REJECTION PIPELINE REPORT INCLUDES Panorama of Lung Transplant Rejection pipeline markets including statistics on therapeutic drugs and companies involved Lung Transplant Rejection Pipeline candidates across various development ...
August 2018
50 pages
Lupus Nephritis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LUPUS NEPHRITIS PIPELINE REPORT INCLUDES Panorama of Lupus Nephritis pipeline markets including statistics on therapeutic drugs and companies involved Lupus Nephritis Pipeline candidates across various development ...
August 2018
110 pages
Lyme Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LYME DISEASE PIPELINE REPORT INCLUDES Panorama of Lyme Disease pipeline markets including statistics on therapeutic drugs and companies involved Lyme Disease Pipeline candidates across various development ...
August 2018
30 pages
Lymphatic Filariasis (Elephantiasis) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LYMPHATIC FILARIASIS (ELEPHANTIASIS) PIPELINE REPORT INCLUDES Panorama of Lymphatic Filariasis (Elephantiasis) pipeline markets including statistics on therapeutic drugs and companies involved Lymphatic Filariasis (Elephantiasis) Pipeline candidates across various development ...
August 2018
20 pages
Macular Edema R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MACULAR EDEMA PIPELINE REPORT INCLUDES Panorama of Macular Edema pipeline markets including statistics on therapeutic drugs and companies involved Macular Edema Pipeline candidates across various development ...
August 2018
40 pages
Major Depressive Disorder R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MAJOR DEPRESSIVE DISORDER PIPELINE REPORT INCLUDES Panorama of Major Depressive Disorder pipeline markets including statistics on therapeutic drugs and companies involved Major Depressive Disorder Pipeline candidates across various development ...
August 2018
160 pages
Male Hypogonadism R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MALE HYPOGONADISM PIPELINE REPORT INCLUDES Panorama of Male Hypogonadism pipeline markets including statistics on therapeutic drugs and companies involved Male Hypogonadism Pipeline candidates across various development ...
August 2018
80 pages
Male Infertility R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MALE INFERTILITY PIPELINE REPORT INCLUDES Panorama of Male Infertility pipeline markets including statistics on therapeutic drugs and companies involved Male Infertility Pipeline candidates across various development ...
August 2018
30 pages
Malignant Pleural Effusion R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MALIGNANT PLEURAL EFFUSION PIPELINE REPORT INCLUDES Panorama of Malignant Pleural Effusion pipeline markets including statistics on therapeutic drugs and companies involved Malignant Pleural Effusion Pipeline candidates across various development ...
August 2018
30 pages
Marburg Hemorrhagic Fever R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MARBURG HEMORRHAGIC FEVER PIPELINE REPORT INCLUDES Panorama of Marburg Hemorrhagic Fever pipeline markets including statistics on therapeutic drugs and companies involved Marburg Hemorrhagic Fever Pipeline candidates across various development ...
August 2018
60 pages
Measles R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF MEASLES PIPELINE REPORT INCLUDES Panorama of Measles pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Medullary Thyroid Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MEDULLARY THYROID CANCER PIPELINE REPORT INCLUDES Panorama of Medullary Thyroid Cancer pipeline markets including statistics on therapeutic drugs and companies involved Medullary Thyroid Cancer Pipeline candidates across various development ...
August 2018
80 pages
Medulloblastoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF MEDULLOBLASTOMA PIPELINE REPORT INCLUDES Panorama of Medulloblastoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
160 pages
Melasma (Chlosma) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MELASMA (CHLOSMA) PIPELINE REPORT INCLUDES Panorama of Melasma (Chlosma) pipeline markets including statistics on therapeutic drugs and companies involved Melasma (Chlosma) Pipeline candidates across various development ...
August 2018
20 pages
Melioidosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF MELIOIDOSIS PIPELINE REPORT INCLUDES Panorama of Melioidosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Meniere Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MENIERE DISEASE PIPELINE REPORT INCLUDES Panorama of Meniere Disease pipeline markets including statistics on therapeutic drugs and companies involved Meniere Disease Pipeline candidates across various development ...
August 2018
40 pages
Meningioma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF MENINGIOMA PIPELINE REPORT INCLUDES Panorama of Meningioma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
200 pages
Meningitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF MENINGITIS PIPELINE REPORT INCLUDES Panorama of Meningitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Metachromatic Leukodystrophy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF METACHROMATIC LEUKODYSTROPHY PIPELINE REPORT INCLUDES Panorama of Metachromatic Leukodystrophy pipeline markets including statistics on therapeutic drugs and companies involved Metachromatic Leukodystrophy Pipeline candidates across various development ...
August 2018
30 pages
Metastatic Hepatocellular Carcinoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF METASTATIC HEPATOCELLULAR CARCINOMA PIPELINE REPORT INCLUDES Panorama of Metastatic Hepatocellular Carcinoma pipeline markets including statistics on therapeutic drugs and companies involved Metastatic Hepatocellular Carcinoma Pipeline candidates across various development ...
August 2018
100 pages
Metastatic Ovarian Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF METASTATIC OVARIAN CANCER PIPELINE REPORT INCLUDES Panorama of Metastatic Ovarian Cancer pipeline markets including statistics on therapeutic drugs and companies involved Metastatic Ovarian Cancer Pipeline candidates across various development ...
August 2018
80 pages
Microscopic Polyangiitis (MPA) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MICROSCOPIC POLYANGIITIS (MPA) PIPELINE REPORT INCLUDES Panorama of Microscopic Polyangiitis (MPA) pipeline markets including statistics on therapeutic drugs and companies involved Microscopic Polyangiitis (MPA) Pipeline candidates across various development ...
August 2018
30 pages
Middle East Respiratory Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF MIDDLE EAST RESPIRATORY SYNDROME PIPELINE REPORT INCLUDES Panorama of Middle East Respiratory Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Middle East Respiratory Syndrome Pipeline candidates across ...
August 2018
40 pages
Mild Cognitive Impairment R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MILD COGNITIVE IMPAIRMENT PIPELINE REPORT INCLUDES Panorama of Mild Cognitive Impairment pipeline markets including statistics on therapeutic drugs and companies involved Mild Cognitive Impairment Pipeline candidates across various development ...
August 2018
100 pages
Mucopolysaccharidosis Type II (Hunter Syndrome ) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF MUCOPOLYSACCHARIDOSIS TYPE II (HUNTER SYNDROME ) PIPELINE REPORT INCLUDES Panorama of Mucopolysaccharidosis Type II (Hunter Syndrome ) pipeline markets including statistics on therapeutic drugs and companies involved Mucopolysaccharidosis Type II (Hunter Syndrome ) Pipeline candidates across ...
August 2018
50 pages
MucopolysaccharidosisType I (Hurler Syndrome) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF MUCOPOLYSACCHARIDOSISTYPE I (HURLER SYNDROME) PIPELINE REPORT INCLUDES Panorama of MucopolysaccharidosisType I (Hurler Syndrome) pipeline markets including statistics on therapeutic drugs and companies involved MucopolysaccharidosisType I (Hurler Syndrome) Pipeline candidates across ...
August 2018
50 pages
Multiple System Atrophy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MULTIPLE SYSTEM ATROPHY PIPELINE REPORT INCLUDES Panorama of Multiple System Atrophy pipeline markets including statistics on therapeutic drugs and companies involved Multiple System Atrophy Pipeline candidates across various development ...
August 2018
40 pages
Mumps R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF MUMPS PIPELINE REPORT INCLUDES Panorama of Mumps pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
20 pages
Muscle Atrophy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MUSCLE ATROPHY PIPELINE REPORT INCLUDES Panorama of Muscle Atrophy pipeline markets including statistics on therapeutic drugs and companies involved Muscle Atrophy Pipeline candidates across various development ...
August 2018
30 pages
Muscle Invasive Bladder Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF MUSCLE INVASIVE BLADDER CANCER PIPELINE REPORT INCLUDES Panorama of Muscle Invasive Bladder Cancer pipeline markets including statistics on therapeutic drugs and companies involved Muscle Invasive Bladder Cancer Pipeline candidates across ...
August 2018
90 pages
Muscular Dystrophy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MUSCULAR DYSTROPHY PIPELINE REPORT INCLUDES Panorama of Muscular Dystrophy pipeline markets including statistics on therapeutic drugs and companies involved Muscular Dystrophy Pipeline candidates across various development ...
August 2018
120 pages
Myasthenia Gravis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MYASTHENIA GRAVIS PIPELINE REPORT INCLUDES Panorama of Myasthenia Gravis pipeline markets including statistics on therapeutic drugs and companies involved Myasthenia Gravis Pipeline candidates across various development ...
August 2018
100 pages
Myocardial Fibrosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MYOCARDIAL FIBROSIS PIPELINE REPORT INCLUDES Panorama of Myocardial Fibrosis pipeline markets including statistics on therapeutic drugs and companies involved Myocardial Fibrosis Pipeline candidates across various development ...
August 2018
70 pages
Myocardial Ischemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MYOCARDIAL ISCHEMIA PIPELINE REPORT INCLUDES Panorama of Myocardial Ischemia pipeline markets including statistics on therapeutic drugs and companies involved Myocardial Ischemia Pipeline candidates across various development ...
August 2018
50 pages
Myocarditis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF MYOCARDITIS PIPELINE REPORT INCLUDES Panorama of Myocarditis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Myotonic Dystrophy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF MYOTONIC DYSTROPHY PIPELINE REPORT INCLUDES Panorama of Myotonic Dystrophy pipeline markets including statistics on therapeutic drugs and companies involved Myotonic Dystrophy Pipeline candidates across various development ...
August 2018
50 pages
Narcolepsy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF NARCOLEPSY PIPELINE REPORT INCLUDES Panorama of Narcolepsy pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Nasal Polyposis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF NASAL POLYPOSIS PIPELINE REPORT INCLUDES Panorama of Nasal Polyposis pipeline markets including statistics on therapeutic drugs and companies involved Nasal Polyposis Pipeline candidates across various development ...
August 2018
40 pages
Nasal Polyps R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF NASAL POLYPS PIPELINE REPORT INCLUDES Panorama of Nasal Polyps pipeline markets including statistics on therapeutic drugs and companies involved Nasal Polyps Pipeline candidates across various development ...
August 2018
50 pages
